Piramal Pharma P/E Ratio
Piramal Pharma (PPLPHARMA) P/E ratio is not applicable — EPS (TTM) ₹-2.46, 3 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has reported losses in the last 3 quarters. P/E ratio is not applicable during loss periods.
Consecutive Loss Quarters: 3
Current EPS: ₹-2.46
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -0.07 | -9 | Loss |
| Jun 2026 | -0.52 | -69 | Loss |
| Sept 2025 | -0.75 | -99 | Loss |
| Mar 2025 | 1.16 | 154 | Profit |
| Jun 2025 | -0.62 | -82 | Loss |
| Dec 2025 | -1.03 | -136 | Loss |
| Sept 2024 | 0.17 | 23 | Profit |
| Mar 2024 | 0.77 | 101 | Profit |
Healthcare Peers with Valid P/E Ratios — PPLPHARMA Comparison
Healthcare sector average P/E 56.79, median 32.06 — PPLPHARMA excluded (negative EPS).
Sector Average PE
56.79
Sector Median PE
32.06
Lowest PE
1.99
Profitable Companies
200
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Piramal Pharma share price chart.
- Also explore Piramal Pharma share price performance to track price trends across different timeframes.